Dowling & Yahnke LLC

SEC CIK: 0001133197
Latest filing: Nov 3, 2022

SEC filings (opens in a new tab)

MRTX holding history

Mirati Therapeutics, Inc. in every 13F filed by Dowling & Yahnke LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MRTX overview All 13F holders of MRTX Full Q3 2022 holdings

Shares (Q3 2022): 7,900
Value: $552.0K
% of portfolio: <0.1%
Quarters held: 2; Since Q4 2021

Holdings of MRTX by Dowling & Yahnke LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2022	7,900	$552.0K	<0.1%	+7,900	New	Holders
Q1 2022	0	$0	0.0%	−1,900−100.0%	Sold out	Holders
Q4 2021	1,900	$279.0K	<0.1%	+1,900	New	Holders